Skip to main content

Table 2 Numbers of first invasive cancers and crude cancer incidence rates in the T2D cohort

From: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort

Cancer type (ICD-10)

Men

Women

 

N = 12.650; 41.170 py

N = 14.092; 47.603 py

Any cancer (excluding C 44*)

759 (18.4 per 1 000 py)

605 (12.7 per 1 000 py)

Liver (C 22)

23 (0.6 per 1 000 py)

10 (0.2 per 1 000 py)

Pancreas (C 25)

22 (0.5 per 1 000 py)

27 (0.7 per 1 000 py)

Breast (C 50)

2 (0.05 per 1 000 py)

129 (2.7 per 1 000 py)

Prostate (C 61)

132 (3.2 per 1 000 py)

-

Colorectal (C18 - C21)

107 (2.6 per 1 000 py)

88 (1.8 per 1 000 py)

Lung (C34)

121 (2.9 per 1 000 py)

42 (0.9 per 1 000 py)

  1. *C44 ( Other malignant neoplasms of skin)
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us